NCT00130468View on ClinicalTrials.gov

TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

May 31, 2006

Conditions
Osteoarthritis
Interventions
DRUG

Hyalgan (sodium hyaluronate)

Trial Locations (1)

08807

Sanofi-Aventis Inc, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY